XML 52 R42.htm IDEA: XBRL DOCUMENT v3.23.1
Long-Term Investments (Details) - Schedule of balance sheet - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2023
Dec. 31, 2022
BioFirst [Member]    
Condensed Balance Sheet Statements, Captions [Line Items]    
Current Assets $ 1,958,500 $ 1,543,152
Non-current Assets 801,410 739,472
Current Liabilities 1,675,194 2,663,051
Non-current Liabilities 357,150 103,447
Stockholders’ Equity (Deficit) 727,566 (483,874)
Rgene [Member]    
Condensed Balance Sheet Statements, Captions [Line Items]    
Current Assets 54,987 68,302
Non-current Assets 288,160 303,893
Current Liabilities 2,491,974 2,478,868
Non-current Liabilities 2,048 2,441
Stockholders’ Equity (Deficit) $ (2,150,875) $ (2,109,114)